halofuginone has been researched along with hydroxyproline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagler, A; Nyska, A; Nyska, M; Pines, M; Porat, S; Rivlin, E; Shoshan, S | 1 |
Breuer, R; Goldstein, RH; Or, R; Segel, MJ; Tzurel, A | 1 |
Gildor, T; Mawasi, N; Ohayon, O; Paizi, M; Pevzner, A; Pines, M; Rojkind, M; Spira, G; Tryvitz, A | 1 |
Akpolat, N; Alpay, HC; Dabak, H; Isik, O; Karlidag, T; Kaygusuz, I; Keles, E; Serin, M; Yalcin, S | 1 |
4 other study(ies) available for halofuginone and hydroxyproline
Article | Year |
---|---|
Topically applied halofuginone, an inhibitor of collagen type I transcription, reduces peritendinous fibrous adhesions following surgery.
Topics: Animals; Chickens; Collagen; Gene Expression Regulation; Hydroxyproline; Inflammation; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Statistics, Nonparametric; Tendon Injuries; Tissue Adhesions | 1996 |
Halofuginone does not reduce fibrosis in bleomycin-induced lung injury.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Bleomycin; Blotting, Northern; Bronchoalveolar Lavage Fluid; Cell Count; Collagen; Fibroblasts; Gene Expression Regulation; Hydroxyproline; Intubation, Intratracheal; Lung; Male; Piperidines; Pulmonary Fibrosis; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; RNA; Transforming Growth Factor beta | 2002 |
Halofuginone upregulates the expression of heparanase in thioacetamide-induced liver fibrosis in rats.
Topics: Animals; Glucuronidase; Hydroxyproline; Liver Cirrhosis, Experimental; Liver Regeneration; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thioacetamide; Transfection; Up-Regulation; Vascular Endothelial Growth Factor A | 2008 |
The effects of methylprednisolone and halofuginone on preventing esophageal and hypopharyngeal fibrosis in delivered radiotherapy.
Topics: Animals; Anti-Inflammatory Agents; Esophageal Stenosis; Esophagus; Female; Hydroxyproline; Hypopharynx; Injections, Intramuscular; Injections, Intraperitoneal; Methylprednisolone; Piperidines; Premedication; Protein Synthesis Inhibitors; Quinazolinones; Radiation Pneumonitis; Rats; Rats, Wistar | 2010 |